Evidence map›Paper›PMID 27930613›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2017

Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.

Deanna Kerrigan, Jessie Mbwambo, Samuel Likindikoki, Sarah Beckham, Ard Mwampashi, Catherine Shembilu, Andrea Mantsios, Anna Leddy, Wendy Davis, Noya Galai

Registry-linked trialOpen access · hybridAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02281578 (Community-based Combination HIV Prevention in Tanzanian Women at Heightened Risk), which is not on this map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
28.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02281578 nacompletednot on this map

Community-based Combination HIV Prevention in Tanzanian Women at Heightened Risk

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2015 to 2018Enrolled496ConditionsHIVArmsCommunity-based combination HIV prevention intervention, Standard of care HIV services
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Deanna Kerrigan*Department of Health Behavior and Society, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; ‡Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; §Department of Statistics, The University of Haifa, Haifa, Israel.
Jessie Mbwambo
Samuel Likindikoki
Sarah Beckham
Ard Mwampashi
Catherine Shembilu
Andrea Mantsios
Anna Leddy
Wendy Davis
Noya Galai
Johns Hopkins University · USMuhimbili University of Health and Allied Sciences · TZUniversity of Haifa · IL

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Community-based combination HIV prevention in Tanzanian women at heightened riskR01MH104044 · NIMH · JOHNS HOPKINS UNIVERSITY · PI KERRIGAN, DEANNA L · 2014 to 2016
$1.7M
NIAID NIH HHS P30 AI094189NIMH NIH HHS R01 MH104044
6 · The paper itself

Abstract

backgroundCommunity empowerment approaches have been found to be effective in responding to HIV among female sex workers (FSWs) in South Asia and Latin America. To date, limited rigorous evaluations of these approaches have been conducted in sub-Saharan Africa.

methodsA phase II community randomized controlled trial is being conducted in Iringa, Tanzania, to evaluate the effectiveness of a community empowerment-based combination HIV prevention model (Project Shikamana) among a stratified sample of HIV-infected and HIV-uninfected FSWs. Cohort members were recruited from entertainment venues across 2 communities in the region using time-location sampling. All study participants gave consent, and were surveyed and screened for HIV at baseline. Primary biological study outcomes are viral suppression among the HIV-infected and remaining free of HIV among HIV-uninfected women.

resultsA cohort of 496 FSWs was established and is currently under follow-up. Baseline HIV prevalence was 40.9% (203/496). Among HIV-infected FSWs, 30.5% (62/203) were previously aware of their HIV status; among those who were aware, 69.4% were on antiretroviral therapy (43/62); and for those on antiretroviral therapy, 69.8% (30/43) were virally suppressed. Factors associated with both HIV infection and viral suppression at baseline included community, age, number of clients, and substance use. Amount of money charged per client and having tested for sexually transmitted infection in the past 6 months were protective for HIV infection. Social cohesion among FSWs was protective for viral suppression.

conclusionsSignificant gaps exist in HIV service coverage and progress toward reaching the 90-90-90 goals among FSWs in Iringa, Tanzania. Community empowerment approaches hold promise given the high HIV prevalence, limited services and stigma, discrimination, and violence.

Indexed as

Community Health ServicesCommunity NetworksAdultCohort StudiesFeasibility StudiesFemaleHealth Services AccessibilityHIV InfectionsHumansPrevalenceSexually Transmitted DiseasesSex WorkersSocial StigmaSurveys and QuestionnairesTanzaniaViolence

Identifiers

PMID27930613
PMCPMC5147044
OpenAlexW2560643990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.